Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis

BACKGROUND: The proton pump inhibitors (PPIs), used to reduce gastric acid secretion, represent one of the most widely used pharmaceutical classes in the world. Their consumption as a risk factor for the evolution of severe forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zippi, Maddalena, Fiorino, Sirio, Budriesi, Roberta, Micucci, Matteo, Corazza, Ivan, Pica, Roberta, de Biase, Dario, Gallo, Claudio Giuseppe, Hong, Wandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058681/
https://www.ncbi.nlm.nih.gov/pubmed/33969059
http://dx.doi.org/10.12998/wjcc.v9.i12.2763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058681/
https://www.ncbi.nlm.nih.gov/pubmed/33969059
http://dx.doi.org/10.12998/wjcc.v9.i12.2763

Ejemplares similares